Bioequivalence and Absolute Bioavailability of a Single Oral Dose of Two Formulations of 0.75 Mg Palonosetron in Healthy Volunteers
Latest Information Update: 07 Nov 2012
At a glance
- Drugs Palonosetron (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Pharmacokinetics
Most Recent Events
- 07 Nov 2012 New trial record